Phebra Acquires Equity Stake in UK Specialty Hospital Pharma Company Flexipharm Austrading

– Phebra takes part ownership of Flexipharm Austrading through share purchase

– Builds on Phebra’s Existing UK Distribution Agreement

– Strengthens Phebra’s Presence in UK and Europe

SYDNEY and BOURNE END, EnglandNov. 3, 2021 /PRNewswire/ — Leading Australian pharmaceutical group Phebra Holdings (‘Phebra’) is pleased to announce that it has completed a share purchase agreement with the UK hospital specialty pharmaceutical company Flexipharm Austrading Limited (‘FAL’).

Read more…

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...

GET IN TOUCH